$12.50
-0.19-1.5%
Last update: Nov 6, 4:00 PM

The average analyst price target for NeuroPace is $17.69, 41.5% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $8 to $22. The latest change came on Sep 18, 2026, when Keybanc initiated coverage of NeuroPace with an Overweight rating and a $18 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months